Aristeidis Roubanis completed his BSc in Biomedical Science from Queen Mary University of London, followed by an MSc in Infection and Immunity at UCL. With a strong interest in immunology, he conducted research at the William Harvey Research Institute on tertiary lymphoid structures in rheumatic diseases and explored the role of intestinal dysbiosis in rheumatoid arthritis for his MSc thesis. He then pursued a PhD at the Centre of Immunology and Infectious Diseases, INSERM, in Paris, investigating the metabolism of regulatory T cells using a novel in vivo methodological approach and conditional knockout mice. In Feb 2025, he joined the Translational & Clinical Immunology lab to examine immune dysregulation in the development of long COVID.